A recent retrospective study suggests osteocalcin could be a promising tool for identifying CS in postmenopausal women (age > 45 years) with osteoporosis (from those without CS) [AuROC: 0.960 (95% CI 0.892-1.000)] (293). The gene discussed is BGLAP; the disease is osteoporosis.